Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Thalisson A de SouzaMulti-User Characterization and Analysis Laboratory, Research Institute for Drugs and Medicines (IpeFarM), Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0002-6000-8747
Luiz H A PereiraMulti-User Characterization and Analysis Laboratory, Research Institute for Drugs and Medicines (IpeFarM), Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.
Alan F AlvesLaboratory of Cheminformatics, Program of Post-Graduation on Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0001-6042-1075
Douglas DouradoDepartment of Immunology, Instituto Aggeu Magalhães, Fiocruz, Recife 50670-420, Brazil.ORCID 0000-0003-3445-5217
Jociano da S LinsMulti-User Characterization and Analysis Laboratory, Research Institute for Drugs and Medicines (IpeFarM), Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0009-0007-3373-6187
Marcus T ScottiLaboratory of Cheminformatics, Program of Post-Graduation on Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0003-4863-8057
Luciana ScottiLaboratory of Cheminformatics, Program of Post-Graduation on Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0003-1866-4107
Lucas S AbreuDepartment of Organic Chemistry, Universidade Federal Fluminense, Niterói 24220-900, Brazil.ORCID 0000-0001-5620-8095
Josean F TavaresMulti-User Characterization and Analysis Laboratory, Research Institute for Drugs and Medicines (IpeFarM), Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0003-0293-2605
Marcelo S SilvaMulti-User Characterization and Analysis Laboratory, Research Institute for Drugs and Medicines (IpeFarM), Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.ORCID 0000-0003-3451-8468
Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Financiadora de Estudos e Projetos INCT-Rennofito, nº 465536/2014-0
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.